Abstract Haematological malignancies are life-threatening disorders requiring specialized care, including costly medications and therapies. In resource-limited settings, the financial burden often limits access to optimal treatment. Patient Access Programs (PAP) and Compassionate Access Programs (CAP) have been instrumental in bridging this gap, ensuring equitable treatment access. This article explores the benefits

             Abstract Chronic Myeloid Leukemia (CML) is a haematologic malignancy effectively managed with tyrosine kinase inhibitors (TKIs). However, social and financial barriers often limit optimal treatment, especially in low-resource settings like Bangladesh. This study aimed to evaluate the knowledge, attitudes, and practices (KAP) of CML patients regarding TKI therapy and

Background and Aims: Haemophilia is a rare bleeding disorder that poses significant health and social challenges, especially in low-income countries where stigma and misconceptions hinder effective management. Stigma leads to social isolation, discrimination, and psychological distress among patients and caregivers, while also impacting healthcare access and treatment adherence. This study aims to explore the stigma